Drugs / NPO-11
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT03263910 | Aug 2017 → Aug 2018 | — | Nihon Pharmaceutical Co., Ltd | Completed | No outcome recorded |
| Phase 3 | NCT00745459 | Sep 2008 → Apr 2009 | stomach disorder | Nihon Pharmaceutical Co., Ltd | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00740324 Comparator | Aug 2008 → Mar 2009 | — | Nihon Pharmaceutical Co., Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NPO-11 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00745459 ↗ |
| Route | Other | “single intragastric dose of NPO-11” NCT00740324 ↗ |